Dermavant Sciences, Inc.: Dermavant to Present Data from Multiple Studies of VTAMA (tapinarof) cream, 1% at the 2023 Winter Clinical Dermatology Conference
- Seven posters will include clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and atopic dermatitis (AD), including data from the successful pediatric maximum usage study